Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. in April 2003 and is headquartered in Framingham, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Pulmatrix Inc market cap is $4.71M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pulmatrix Inc 52 week high is $4.94 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pulmatrix Inc 52 week low is $1.06 as of November 17, 2026.
Pulmatrix Inc stock price today is $1.33.
Pulmatrix Inc stock price yesterday was $1.29.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Pulmatrix Inc's P/E ratio is -1.21.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Pulmatrix Inc P/B ratio is 3.0531.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Pulmatrix Inc 50-day moving average is $1.46.